2024 U.S. POC/Decentralized Diagnostic Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts
![](/report_cover/2215/2024-us-pocdecentralized-diagnostic-testing-market-country-supplier-shares-test-volume-n-sales-segment-forecasts_en.gif)
This new report from LeadingMarketResearch.com provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis%li%Review of the 10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. %li%Five-year test volume and reagent sales forecasts for over 300 chemistry, ; &immunodiagnostic, microbiology, hematology and coagulation procedures by market segment: %li%Home/Personal Testing %li%Physician Offices/Group Practices %li%Emergency Rooms %li%Operating/Recovery Suites %li%ICUs/CCUs %li%Cancer Clinics %li%Ambulatory Care Centers %li%Surgery Centers %li%Nursing Homes%li%Birth Centers and by test category: %li%Routine and Special Chemistry %li%Microbiology/Infectious Diseases %li%Hematology %li%Flow Cytometry %li%Coagulation %li%Immunoproteins%li%Drugs of Abuse%li%TDM%li%Endocrine Function%li%Tumor Markers Sales and Market Share Analysis%li%Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products%li%Analysis of over 130 diagnostic procedures. %li%Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review%li%Emerging technologies and their applications for POC testing. %li%Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test. Competitive Assessments%li%Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations%li%Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. %li%Design criteria for POC testing products. %li%Alternative business expansion strategies. %li%Potential market entry barriers and risks. Methodology
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications,
manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications,
manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Introduction
Executive Summary
Rationale for Testing Decentralization
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CHOLESTEROL
12. CHOLINESTERASE
13. CREATININE
14. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. FERRITIN
16. FOLLATE/FOLIC ACID
Table of Contents (continued)
17. FRUCTOSAMINE
18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
19. GLUCOSE
20. HIGH DENSITY LIPOPROTEIN (HDL)
21. IRON
22. LACTATE DEHYDROGENASE (LDH)
23. MAGNESIUM
24. PHOSPHORUS
25. PROTEIN
26. TRIGLYCERIDES
27. TROPONIN
28. URIC ACID
29. URINALYSIS
30. VITAMIN B12
Infectious Disease Tests
1. AIDS
2. ADENOVIRUS
3. CAMPYLOBACTER
4. CANDIDA
5. CHLAMYDIA
6. CLOSTRIDIUM DIFFICILE
7. CYTOMEGALOVIRUS
8. ENTEROVIRUSES
9. EPSTEIN-BARR VIRUS
10. GONORRHEA
11. HELICOBACTER PYLORI
12. HEPATITIS
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. HERPES SIMPLEX VIRUS
14. HUMAN HERPES VIRUS-6 (HHV-6)
15. INFLUENZA VIRUSES
16. LEGIONELLA
17. LYME DISEASE
18. MEASLES (RUBEOLA)
19. MENINGITIS
Executive Summary
Rationale for Testing Decentralization
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CHOLESTEROL
12. CHOLINESTERASE
13. CREATININE
14. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. FERRITIN
16. FOLLATE/FOLIC ACID
Table of Contents (continued)
17. FRUCTOSAMINE
18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
19. GLUCOSE
20. HIGH DENSITY LIPOPROTEIN (HDL)
21. IRON
22. LACTATE DEHYDROGENASE (LDH)
23. MAGNESIUM
24. PHOSPHORUS
25. PROTEIN
26. TRIGLYCERIDES
27. TROPONIN
28. URIC ACID
29. URINALYSIS
30. VITAMIN B12
Infectious Disease Tests
1. AIDS
2. ADENOVIRUS
3. CAMPYLOBACTER
4. CANDIDA
5. CHLAMYDIA
6. CLOSTRIDIUM DIFFICILE
7. CYTOMEGALOVIRUS
8. ENTEROVIRUSES
9. EPSTEIN-BARR VIRUS
10. GONORRHEA
11. HELICOBACTER PYLORI
12. HEPATITIS
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. HERPES SIMPLEX VIRUS
14. HUMAN HERPES VIRUS-6 (HHV-6)
15. INFLUENZA VIRUSES
16. LEGIONELLA
17. LYME DISEASE
18. MEASLES (RUBEOLA)
19. MENINGITIS